Showing results (341-350 of 596) with videos related to
Sort By:
Pageof 60
Biochemical and Biophysical Research Communications|December 4, 1996
An endogenous cannabinoid as an endothelium-derived vasorelaxantM D Randall, S P Alexander, T Bennett, et al.Papers in Applied Geography|June 6, 2022
Spatial and Descriptive Analysis of Smoke and Vape Shop Locations Focusing on A Cancer Center Neighboring Catchment AreaKimlin Tam Ashing, Gaole Song, Timothy O'Connor, et al.Biosensors|January 15, 2015
Comparison of surface plasmon resonance, resonant waveguide grating biosensing and enzyme linked immunosorbent assay (ELISA) in the evaluation of a dengue virus immunoassayDongmei Hu, Scott R Fry, Johnny X Huang, et al.Archives of Surgery (Chicago, Ill. : 1960)|October 1, 1993
Gasless laparoscopy and conventional instruments. The next phase of minimally invasive surgeryR S Smith, W R Fry, E K Tsoi, et al.Biomedical Microdevices|April 21, 2023
A digitally driven manufacturing process for high resolution patterning of cell formationsMatthew A A Smith, M Ibrahim Khot, Silvia Taccola, et al.Journal of Neurology|June 11, 2013
Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the CONFIRM studyMichael Hutchinson, Robert J Fox, David H Miller, et al.Current Medical Research and Opinion|October 18, 2013
BG-12 (dimethyl fumarate): a review of mechanism of action, efficacy, and safetyRobert J Fox, Mariko Kita, Stanley L Cohan, et al.Journal of Neurology|October 2, 2014
Magnetization transfer ratio in the delayed-release dimethyl fumarate DEFINE studyDouglas L Arnold, Ralf Gold, Ludwig Kappos, et al.Journal of Neurology|July 4, 2014
Effects of delayed-release dimethyl fumarate on MRI measures in the Phase 3 DEFINE studyDouglas L Arnold, Ralf Gold, Ludwig Kappos, et al.Communications Biology|February 3, 2025
Devaluing memories of reward: a case for dopamineBenjamin R Fry, Nicolette Russell, Victoria Fex, et al.Pageof 60